Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Synedent
- Development stage
- Unknown
- Lead developer
- Synedgen
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
Synedent is an over-the-counter oral rinse developed by Synedgen, specifically through its Prisyna oral health care business unit. The product line includes Synedent FLX, which contains sodium fluoride (0.02%), and a fluoride-free variant. Both formulations leverage a patented chemistry combining chitosan and arginine to provide a gentle, alcohol-free cleansing action that protects teeth against acids produced by plaque bacteria. Synedent is primarily indicated for oral health maintenance, the prevention of dental caries, and the promotion of tooth remineralization, offering a non-harsh alternative to traditional mouthwashes.
- Brand names
- SynedentSynedent FLX
Beyond the preview
Go deeper on Synedent.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Synedent.